Related references
Note: Only part of the references are listed.Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: Balancing the risks and benefits
Jeanie Ling Yoong Cheong et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2019)
Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates
Joseph E. Rower et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Prophylactic postnatal corticosteroids: Early hydrocortisone
Olivier Baud et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2019)
Effects of budesonide and surfactant in preterm fetal sheep
T. Brett Kothe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Bronchopulmonary Dysplasia: Executive Summary of a Workshop
Rosemary D. Higgins et al.
JOURNAL OF PEDIATRICS (2018)
Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta-Analysis
Lisa M. Askie et al.
JOURNAL OF PEDIATRICS (2018)
An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia
Jeanie L. Y. Cheong et al.
SEMINARS IN PERINATOLOGY (2018)
Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study
Roberta L. Keller et al.
JOURNAL OF PEDIATRICS (2017)
Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites
Tao Long et al.
NATURE GENETICS (2017)
Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants
Lindsey A. Morrow et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia
Tsu F. Yeh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Antiinflammatory Effects of Budesonide in Human Fetal Lung
Anne Marie Barrette et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
Roberta A. Ballard et al.
JOURNAL OF PEDIATRICS (2016)
Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants
Carl T. D'Angio et al.
JOURNAL OF PEDIATRICS (2016)
Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia
Dirk Bassler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure
Jose R. Castillo-Mancilla et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
Pilot trial of late booster doses of surfactant for ventilated premature infants
J. D. Merrill et al.
JOURNAL OF PERINATOLOGY (2011)
A Follow-up Study of Preterm Infants Given Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants
Huang T. Kuo et al.
JOURNAL OF PEDIATRICS (2010)
Dexamethasone Treatment in the First Week of Life for Preventing Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review
Lex W. Doyle et al.
NEONATOLOGY (2010)
Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: A pilot study
Tsu F. Yeh et al.
PEDIATRICS (2008)
Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology
K Skogstrand et al.
CLINICAL CHEMISTRY (2005)
Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network
BJ Stoll et al.
PEDIATRICS (2002)
Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants
AR Stark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
